PAPER Kaur M, Aran KR

Unraveling the role of Nrf2 in dopaminergic neurons: a review of oxidative stress and mitochondrial dysfunction in Parkinson's disease.

Metab Brain Dis. 2025 Feb 11;40(2):123. PubMed.

PAPER Naranjo L, Sarto J, Nos C, Alcolea D, Rodríguez-Baz I, Navalpotro-Gómez I, Fernández-Lebrero A, Bertrán-Recasens B, Erro ME, Pelayo-Negro AL, Esteve C, Fernández S, Massot-Tarrús A, Boltes A, Torrents A, Guanyabens N, Palomino-García A, Egri N, Lladó A, Balasa M, Romera MA, Antón MD, Couso RS, Sánchez-Valle R, Ruiz-García R, Spanish sCJD Study Group

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.

J Neurol. 2025 Feb 11;272(3):198. PubMed.

PAPER Grünblatt E, Yde Ohki CM, Schmitt-Böhrer GA, Riederer P, Walitza S

Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models.

J Neural Transm (Vienna). 2025 Feb 11; Epub 2025 Feb 11 PubMed.

PAPER Patira R, Shahabadi AZ, Lopez O, Kofler J

aFTLD-U presenting with primary progressive aphasia suggestive of non-fluent type with apraxia of speech.

Neurocase. 2025 Feb 11;:1-4. Epub 2025 Feb 11 PubMed.

PAPER Jin L, Nie L, Deng Y, Khana GJ, He N

The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases.

Cell Prolif. 2025 Feb 11;:e13804. Epub 2025 Feb 11 PubMed.

PAPER Radin DP, Zhong S, Cerne R, Shoaib M, Smith JL, Witkin J, Lippa A

Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Mumtaz, Ahmed F, Rabbani SA, El-Tanani M, Najmi AK, Ali J, Khan MA

Tauopathy in AD: Therapeutic Potential of MARK-4.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Cho Y, Lee J, Kim JS, Jeon Y, Han S, Cho H, Lee Y, Kim TK, Hong JM, Lee Y, Byun Y, Chae M, Park S, Palomera LF, Park SY, Kim H, Kim S, Kang S, Jee JG, An H, Yim JH, Kim SH, Jo DG

RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.

Anim Cells Syst (Seoul). 2025;29(1):122-134. Epub 2025 Feb 7 PubMed.

PAPER Ding J, Long Z, Liu Y, Wang M

Study on influencing factors of age-adjusted Charlson comorbidity index in patients with Alzheimer's disease based on machine learning model.

Front Med (Lausanne). 2025;12:1497662. Epub 2025 Jan 27 PubMed.

PAPER Silva-Llanes I, Madruga E, Martínez A, Lastres-Becker I

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

Front Neurosci. 2024;18:1530809. Epub 2025 Jan 27 PubMed.

PAPER Engelhardt E, Grinberg LT

The underappreciated contribution of Oskar Fischer to the knowledge of Frontotemporal Lobar Degeneration.

Dement Neuropsychol. 2025;19:e20240226. Epub 2025 Feb 10 PubMed.

PAPER Nevzorova KV, Shpilyukova YA, Fedotova EY, Burmak AG, Shabalina AA, Illarioshkin SN

[The experience of diagnosing Alzheimer's disease based on the study of cerebrospinal fluid biomarkers].

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(1):91-97. PubMed.

PAPER Gravitz L

Gains in early-onset dementia with progranulin open new paths for drug discovery.

Nat Biotechnol. 2025 Feb;43(2):151-153. PubMed.

PAPER Balakrishnan NB, Pillai AS, Jose Panackal J, Sreeja PS

Alzheimer's Disease detection and classification using optimized neural network.

Comput Biol Med. 2025 Mar;187:109810. Epub 2025 Feb 11 PubMed.

PAPER Ullah K, Almutairi MH, Abbas MN, Wahab A, Nayab S, Fozia F, Khan MA, Shah ZA, Ahmad I, Almutairi BO, Ziaullah Z

Discovery of Selective β-Secretase (BACE-1) Inhibitors by the Solid-Phase Synthesis of Small Molecular-sized Peptides.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.